RehydraMIST

Stimulates natural saliva.
Supports oral health.

Dry mouth is a

growing clinical problem

Aging population

An increasing proportion of elderly individuals experience reduced natural salivary flow as part of the aging process.

Dry mouth from medication

Common medications such as antidepressants, antihypertensives and antihistamines significantly reduce saliva production as a side effect.

Caries & infection risk

Lower salivary flow compromises the mouth’s natural protective mechanisms, increasing the risk of tooth decay, enamel erosion and oral infections.

How RehydraMIST

works

The formulation activates gustatory receptors, increasing natural saliva secretion and improving oral hydration.

Dry mouth affects daily function and long-term oral health

Reduced salivary flow affects both daily function and oral health homeostasis. Impaired lubrication can compromise speaking and swallowing, while diminished salivary protection increases susceptibility to caries, enamel demineralization and oral infections. What begins as a subjective symptom may progress into clinically significant oral complications.

Salivary dysfunction
Enamel demineralization
Increased infection risk

Clinically

supported

The formulation has been evaluated in multiple controlled clinical trials.

5 randomized controlled trials

The oral spray formulation has been evaluated in five controlled, randomized, double-masked clinical trials.

Observed improvement in dry mouth symptoms

In several studies, improvement in dry mouth symptoms was observed in the intervention group, while no significant improvement was seen in the control group.

Improved Oral Health-Related Quality of Life

In two trials, Oral Health-Related Quality of Life (OHRQoL) was measured, and improvement was observed in the intervention groups.

Studied in elderly and medication-induced populations

The clinical studies included participants suffering from dry mouth due to medication and elderly individuals with xerostomia.

RehydraMIST is classified as a Class IIa medical device under the European MDR regulation, ensuring compliance with strict safety and performance requirements.